Antileishmanial Activity of the Essential Oil fromBixa orellana
- 27 August 2013
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 28 (5), 753-758
- https://doi.org/10.1002/ptr.5055
Abstract
Leishmaniasis is a neglected tropical disease caused by Leishmania protozoa. There is currently no vaccine against leishmaniasis, and chemotherapy remains the only effective control. However, conventional drugs are toxic, expensive, and require long periods of treatment, and resistance to clinical chemotherapeutic agents is emerging. Recent research on plants has shown a successful approach to obtain new antileishmanial alternatives. Herein, the in vitro and in vivo effects of the essential oil from Bixa orellana seeds against Leishmania amazonensis were evaluated. A total of 73 compounds were detected by gas chromatography–mass spectrometry analysis, of which ishwarane (18.6%) and geranylgeraniol (9.1%) were the major components. The oil showed activity against intracellular amastigote form (IC50 = 8.5 µg/mL), while the cytotoxic concentration was sevenfold higher for the host cells. The ability of Bixa oil to control disease progression of established cutaneous leishmaniasis in BALB/c mice was demonstrated, after a treatment with 30 mg/kg by intraperitoneal administration over 14 days. The present study reports for the first time the antileishmanial potentialities of the essential oil from B. orellana. Copyright © 2013 John Wiley & Sons, Ltd.Keywords
This publication has 35 references indexed in Scilit:
- Leishmaniases control: what part for development and what part for research?Clinical Microbiology & Infection, 2011
- In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides ChamParasitology International, 2011
- Evaluation of antileishmanial, cytotoxic and antioxidant activities of essential oils extracted from plants issued from the leishmaniasis-endemic region of Sned (Tunisia)Natural Product Research, 2011
- Effect of Bixa orellana against Leishmania amazonensisResearch in Complementary Medicine, 2011
- Treatment of cutaneous leishmaniasis among travellersJournal of Antimicrobial Chemotherapy, 2004
- Mechanisms of pathogenesis: differences amongst Leishmania speciesTransactions of the Royal Society of Tropical Medicine and Hygiene, 2002
- Antileishmanial Activity of an Indole Alkaloid fromPeschiera australisAntimicrobial Agents and Chemotherapy, 2001
- Efficacy of the Triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous and Visceral LeishmaniasesAntimicrobial Agents and Chemotherapy, 1999
- Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected miceAntimicrobial Agents and Chemotherapy, 1995
- Ishwarane and aristolochene, two new sesquiterpene hydrocarbons from Aristolochia indicaTetrahedron, 1970